[1]
Sung-Han Hsiao, “The Overexpression of ABCG2 Reduces the Efficacy of Volasertib (BI 6727) and GSK641364 in Human S1-M1-80 Colon Carcinoma Cells”, J. Can. Res. Updates, vol. 3, no. 2, pp.  108–116, Apr. 2014.